OTCMKTS:DRUS Bantek (DRUS) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free DRUS Stock Alerts $0.0065 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.0065▼$0.009550-Day Range$0.01▼$0.0252-Week Range$0.00▼$0.11Volume27,011 shsAverage Volume101.81 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Bantek alerts: Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here About Bantek Stock (OTCMKTS:DRUS)Bantek, Inc., an unmanned aerial vehicles (UAV) and related services and technology company, focuses on the distribution and integration of advanced low altitude UAV systems, services, and products worldwide. It also provides product procurement, distribution, and logistics services. In addition, the company offers drone operator training services; and licensed piloted services, such as search and rescue, utility inspection, real estate marketing, construction, engineering, and agriculture. Further, it supplies spare and replacement parts to various federal government agencies, military prime contractors, and commercial customers; and resells insulation jackets to cover mechanical system components, such as valves, steam traps, heat exchangers, flanges, and other mechanical system components. The company was formerly known as Drone USA, Inc. and changed its name to Bantek, Inc. in April 2018. Bantek, Inc. is headquartered in Pine Brook, New Jersey.Read More DRUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DRUS Stock News HeadlinesMarch 13, 2024 | usatoday.comFounder of New York narcotics delivery service gets 12 years for causing 3 overdose deathsJanuary 16, 2024 | bbc.comCan Denmark's world beating drugs maker stay ahead?May 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.December 7, 2023 | health.usnews.comFlorida Medicare Prescription Drug Plans (Part D)September 26, 2023 | bbc.co.ukDerry: Three drug-related deaths last weekend, court toldAugust 21, 2023 | nbcnews.comRobert De Niro’s grandson died from fentanyl, cocaine and other drugs, medical examiner saysJuly 29, 2023 | mirror.co.ukPhiladelphia 'zombie drug' Tranq addicts sway in street in disturbing open-air drug marketJune 10, 2023 | usatoday.comFDA approves new menopause drug for hot flashes, sweating and chillsMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.May 27, 2023 | foxnews.comOver 100,00 Americans died from drug overdoses in 2022, CDC saysMay 25, 2023 | news.yahoo.comWeight loss drugs can lead to muscle loss, too. Is that a bad thing?May 19, 2023 | nbcnews.comAt least 2 cases of drug-resistant ringworm infections found in the U.S., CDC saysMay 9, 2023 | nypost.comCop probed for trying to stop bust of alleged drug dealer — her boyfriend: sourcesMay 9, 2023 | nypost.comNYPD cop claims he was fired after hemp soap caused positive drug testApril 28, 2023 | reuters.comExplainer: After COVID and drug shortages, EU revamps drug lawsApril 19, 2023 | dailymail.co.ukAre we proof that a revolutionary new drug to stop diseases like arthritis and type 1 diabetes really DOES work?April 13, 2023 | nytimes.comDrug Company Leaders Condemn Ruling Invalidating F.D.A.’s Approval of Abortion PillApril 13, 2023 | nypost.com$2 tests to detect ‘tranq’ are first strike at US ‘zombie drug’ epidemicApril 13, 2023 | forbes.comThe ‘Deadliest Drug’ In America Explained: How Xylazine—An Animal Tranquilizer—Is Getting Mixed With FentanylMarch 23, 2023 | usatoday.comThey previously worked with the DEA. Now, they're facing drug charges.February 26, 2023 | news.yahoo.comPhiladelphia’s zombie drug ‘tranq’ already in NYCFebruary 26, 2023 | newsweek.comZombie Drug Tranq Can Lead to Necrosis, Amputations and DeathFebruary 22, 2023 | usnews.comDrug AbuseJanuary 5, 2023 | finance.yahoo.comDrug Discovery Informatics Market All Set for Momentous Growth as Pharma Companies Realize Merits of Informatics Technology in Drug SpaceMarch 8, 2022 | prnewswire.comBantec's Howco Distributing Receives Its First PO to Supply Military Vehicle Kit Parts a Department of Defense Military Contractor - PR NewswireFebruary 2, 2022 | gurufocus.comBantec's Drone USA Receives Pu - GuruFocus.comFebruary 2, 2022 | prnewswire.comBantec's Drone USA Receives Purchase Order to Ultra High-Tech Thermal Drone to a Coastal New Jersey Fire Department - PRNewswireSee More Headlines Receive DRUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bantek and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Aerospace & Defense Sub-IndustryN/A Current SymbolOTCMKTS:DRUS CUSIPN/A CIKN/A Webwww.droneusainc.com Phone203-220-2296FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Michael Bannon (Age 53)Chairman, Pres & CEO Mr. Matthew Wiles (Age 43)COO & Director Dr. Rodrigo Kuntz Rangel (Age 41)CTO & Director Mr. Jeffrey L. Garon (Age 58)CFO & Director Key CompetitorsAAC Clyde Space AB (publ)OTC:ACCMFAccelleron IndustriesOTCMKTS:ACLLYAirbusOTCMKTS:EADSFAMMONASDAQ:POWWPAstro AerospaceOTCMKTS:ASDNView All Competitors DRUS Stock Analysis - Frequently Asked Questions How have DRUS shares performed in 2024? Bantek's stock was trading at $0.0066 at the beginning of 2024. Since then, DRUS shares have decreased by 1.5% and is now trading at $0.0065. View the best growth stocks for 2024 here. What other stocks do shareholders of Bantek own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bantek investors own include Actinium Pharmaceuticals (ATNM), Axsome Therapeutics (AXSM), Chimerix (CMRX), Digi International (DGII), SeaChange International (SEAC), SMTC (SMTX), Xilinx (XLNX), How do I buy shares of Bantek? Shares of DRUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DRUS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bantek Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.